Product
Homepage
/
Products and Services
/
Drug Products
/
Anti-infective Medication

Drug Products

Product categories

News Center

Viwit Pharmaceutical Invites You to Meet at CPHI North America 2023-03-01 10:04:05
Viwit Pharmaceuticals will be participating in the CPHI North America conference this year from April 25- 27，2023 at Pennsylvania Convention Center, in Philadelphia. Welcome to stop by our booth # 1114 and explore how our CDMO services and solutions would benefit your drug development and manufacturing pipeline. We are looking forward to meeting and collaborating with you in the heart of the US pharma Industry!
Viwit Pharmaceutical Is Now Officially GMP Certified by South Korean MFDS 2023-02-27 13:37:56
Shandong, February 13, 2023 -- Viwit Pharmaceutical, an innovation-driven global company providing CDMO services to pharmaceutical and biotech industries, successfully passed the GMP inspection and approved by the South Korean regulatory agency, the Ministry of Food and Drug Safety (MFDS).
Viwit Pharmaceutical Co., Ltd. participated in CPHI Worldwide 2022 held in Frankfurt Germany from November 1st to November 3rd. 2022-11-09 12:43:00
As the world's largest pharmaceutical industry exhibition, CPHI has been successfully held for 30 years. It displays the entire pharmaceutical supply chain, from API, P-MEC to FDF. It becomes the largest annual gathering of pharmaceutical professionals all over the world. Viwit met old friends and new business partners at CPHI. We displayed a wonderful enterprise image with our products and services, and promoted our international business through CPHI.
Viwit participants in CPhI China 2019, booth: W2B28 2019-06-18 01:34:00
CPhI China 2019 will be held at Shanghai New International Expo Center on June 18-20, 2019. Welcome to patronage of Viwit, booth number: W2B28. If you would like to make an appointment in advance, please email us at service@viwit.com.
CPhI India 2018, Booth No. 4.H15 2018-12-12 01:34:00
CPhI India 2018, Booth No. 4.H15 CPhI India 2018 will take place on Dec. 12 - Dec. 14, 2018 at India Expo Center, India. Please visit us on CPhI India 2018, Booth No. 4.H15. If you would like to make an appointment, please send an e-mail to service@viwit.com.
Welcome participants in CPhI India 2018, booth number: 4.H15 2018-12-12 01:32:00
Welcome participants in CPhI India 2018, booth number: 4.H15 CPhI India 2018 will be held from December 12th to 14th, 2018 at the Expo Center in Delhi, India. Welcome to patronage of Viwit, booth number: 4.H15. If you want to make an appointment in advance, please send an email to service@viwit.com

Anti-infective Medication

Clindamycin Phosphate Injection 2ml: 0.3g
Clindamycin Phosphate Injection 2ml: 0.3g
【Drug Name】
    Generic Name: Clindamycin Phosphate Injection
    English Name: Clindamycin Phosphate Injection
【Specification】（1）2ml: 0.3g （2）4ml: 0.6g
【Indications】This product is suitable for the following infectious diseases caused by Gram-positive bacteria：
（1）Tonsillitis, suppurative otitis media, sinusitis, etc.
（2）Acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess and bronchiectasis with infection.
View More+
Clindamycin Phosphate Injection 4ml: 0.6g
Clindamycin Phosphate Injection 4ml: 0.6g
【Drug Name】
    Generic Name: Clindamycin Phosphate Injection
    English Name: Clindamycin Phosphate Injection
【Specification】（1）2ml: 0.3g （2）4ml: 0.6g
【Indications】This product is suitable for the following infectious diseases caused by Gram-positive bacteria: tonsillitis, suppurative otitis media, sinusitis, etc.
View More+
Fleroxacin Injection 10ml: 0.2g
Fleroxacin Injection 10ml: 0.2g
【Drug Name】
    Generic Name: Fleroxacin Injection
    English Name: Fleroxacin Injection
【Specification】 （1）10ml: 0.1g （2）10ml: 0.2g （3）10ml: 0.4g
【Indications】 It can be used for respiratory infections caused by bacteria sensitive to this product: acute bronchitis, acute attack of chronic bronchitis and pneumonia; cystitis, pyelonephritis, prostatitis, epididymitis, Neisseria gonorrhoeae Genitourinary system infections; Salmonella typhi infection, bacterial dysentery and other digestive system infections; skin and soft tissue infections, bone infections, abdominal infections and pelvic infections.
View More+
Levofloxacin hydrochloride Injection 5ml: 0.3g
Levofloxacin hydrochloride Injection 5ml: 0.3g
【Drug name】
    English Name：Levofloxacin Hydrochloride Injection
【Specification】（1）5ml: 0.5g(Calculated as levofloxacin) （2）5ml: 0.3g(Calculated as levofloxacin)
【Indications】 In order to reduce the production of drug-resistant bacteria and ensure the effectiveness of levofloxacin hydrochloride and other antibacterial drugs, levofloxacin is only used to treat or prevent infections that have been or are highly suspected to be caused by sensitive bacteria. When selecting or modifying antimicrobial treatment regimens, the results of bacterial culture and drug susceptibility testing should be considered. If data from these trials are not available for reference, empirical treatment should be conducted based on local epidemiology and pathogen sensitivity.
View More+
Levofloxacin Hydrochloride Injection 5ml: 0.5g
Levofloxacin Hydrochloride Injection 5ml: 0.5g
【Drug Name】
    Generic Name: Levofloxacin Hydrochloride Injection
    English Name: Levofloxacin Hydrochloride Injection
【Specification】 （1）5ml: 0.5g(Calculated as levofloxacin) （2）5ml: 0.3g(Calculated as levofloxacin)
【Indications】 In order to reduce the production of drug-resistant bacteria and ensure the effectiveness of levofloxacin hydrochloride and other antibacterial drugs, levofloxacin is only used to treat or prevent infections that have been or are highly suspected to be caused by sensitive bacteria. When selecting or modifying antimicrobial treatment regimens, the results of bacterial culture and drug susceptibility testing should be considered. If data from these trials are not available for reference, empirical treatment should be conducted based on local epidemiology and pathogen sensitivity.
View More+
Previous page
1
2
search
Confirm
Close
About Us
Company Introduction Corporate History Business Introduction Corporate Governance Company Culture Corporate Honors Viwit Family
R&D and Innovation
R&D Innovation Product Pipeline Achievements
Products
Drug Products Biologics APIs Intermediates Boranes
Innovation
CDMO Project Collaboration In-/Out-Licensing Joint Venture
Sustainable
EHS Energy Quality Supplier
News Center
In 2023 In 2022 In 2021 In 2020 In 2019 In 2018 In 2017 In 2016
Join Us
Talent Philosophy Talent Development Salary and Benefits Campus Recruiting Social Recruitment
Contact Us
Online Message Contact Us
dp EN
dp 中文

wz

wz